0001415889-25-012678.txt : 20250512 0001415889-25-012678.hdr.sgml : 20250512 20250512170016 ACCESSION NUMBER: 0001415889-25-012678 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250508 FILED AS OF DATE: 20250512 DATE AS OF CHANGE: 20250512 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Facchini Peter J. CENTRAL INDEX KEY: 0001883966 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38286 FILM NUMBER: 25935820 MAIL ADDRESS: STREET 1: 155 RANCHRIDGE DRIVE NW CITY: CALGARY, ALBERTA STATE: Z4 ZIP: T3G 1W1 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Enveric Biosciences, Inc. CENTRAL INDEX KEY: 0000890821 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 954484725 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4851 TAMIAMI TRAIL N, SUITE 200 CITY: NAPLES STATE: FL ZIP: 34103 BUSINESS PHONE: 239-302-1707 MAIL ADDRESS: STREET 1: 4851 TAMIAMI TRAIL N, SUITE 200 CITY: NAPLES STATE: FL ZIP: 34103 FORMER COMPANY: FORMER CONFORMED NAME: AMERI Holdings, Inc. DATE OF NAME CHANGE: 20150527 FORMER COMPANY: FORMER CONFORMED NAME: SPATIALIZER AUDIO LABORATORIES INC DATE OF NAME CHANGE: 19950323 4 1 form4-05122025_050503.xml X0508 4 2025-05-08 0000890821 Enveric Biosciences, Inc. ENVB 0001883966 Facchini Peter J. C/O ENVERIC BIOSCIENCES, INC. 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 false true false false CHIEF INNOVATION OFFICER 0 Common Stock 2025-05-08 4 A 0 24717 0 A 33058 D Represents the restricted stock units (the "RSUs") granted to the reporting person pursuant to the Enveric Biosciences, Inc. (the "Company") 2020 Long-Term Incentive Plan, as amended. For each vested restricted stock unit, the reporting person will be entitled to receive one share of common stock. One-fourth of the RSUs will vest upon the one-year anniversary of the date of issuance. An additional one-thirty-sixth of the RSUs will vest each month following the first vesting date. Any remaining RSUs will vest on the fourth anniversary of the date of issuance. Vesting is conditioned upon continued employment by the Company. On January 29, 2025, the common stock of the Issuer began trading on a split-adjusted basis, pursuant to which every 15 shares of issued and outstanding common stock were reclassified as one share of common stock (the "Reverse Stock Split"). The amount of securities reported in this Form 4 has been adjusted to reflect the Reverse Stock Split. /s/ Peter J. Facchini 2025-05-12